Cohen Matthew Gregory reported ARWR

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002141314-26-000004

Machine-readable

Structured copy

Timestamps

Event (reported)

Jun 15, 2026

Published

Jun 17, 2026

Ingested by INSIDER

Nov 5, 03:52 UTC

Last re-read

Nov 5, 03:52 UTC

Extracted facts

Filer

Cohen Matthew Gregory

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

ARROWHEAD PHARMACEUTICALS, INC.

Ticker

ARWR

Shares

11.9K

Price per share

$0

Execution date (reported)

Jun 15, 2026

Owned after transaction

11.9K shares

Days from execution to publication

2

What this establishes

Cohen Matthew Gregory filed this Form 4 reporting a grant or award of ARWR on Jun 15, 2026. It became public on Jun 17, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Cohen Matthew Gregorycik:0002141314

Issuer

ARROWHEAD PHARMACEUTICALS, INC.cik:0000879407

Revision history · 0

No field has changed since this record was first ingested.